Clinical Trials - MNPR

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06617169Dose-Escalation of MNPR-101-PCTA-177Lu in Solid TumorsRECRUITINGPHASE12024-10-082027-012026-12
NCT06337084Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid TumorsRECRUITINGPHASE12024-05-302026-042026-04
NCT05043649Camsirubicin + Pegfilgrastim to Determine MTD in ASTSTERMINATEDPHASE12021-09-222024-05-132023-10-31
NCT04648020Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.TERMINATEDPHASE2, PHASE32021-02-112023-05-142023-05-14